In Huntington's disease (HD), expansion of CAG codons in the huntingtin gene (HTT) leads to the aberrant formation of protein aggregates and the differential degeneration of striatal medium spiny neurons (MSNs). Modeling HD using patient-specific MSNs has been challenging, as neurons differentiated from induced pluripotent stem cells are free of aggregates and lack an overt cell death phenotype. Here we generated MSNs from HD patient fibroblasts through microRNA-based direct neuronal conversion, bypassing the induction of pluripotency and retaining age signatures of the original fibroblasts. We found that patient MSNs consistently exhibited mutant HTT (mHTT) aggregates, mHTT-dependent DNA damage, mitochondrial dysfunction and spontaneous degeneration in culture over time. We further provide evidence that erasure of age stored in starting fibroblasts or neuronal conversion of presymptomatic HD patient fibroblasts results in differential manifestation of cellular phenotypes associated with HD, highlighting the importance of age in modeling late-onset neurological disorders. 
H
D is a progressive neurodegenerative disorder caused by an abnormal expansion of CAG codons in the huntingtin (HTT) gene 1, 2 . HD symptoms typically manifest in midlife and may include motor deficits, psychiatric symptoms and cognitive decline Moreover, CAG repeat length is directly correlated to the severity of the disease and inversely related to the age of onset 5 . Expanded CAG trinucleotides encode a polyglutamine stretch that can accumulate into proteinaceous cytoplasmic and intranuclear aggregates that are thought to be neurotoxic 3 , although the formation of inclusion bodies has also been suggested to be a neuroprotective mechanism 6 . HD pathology is characterized by the selective degeneration of MSNs while other neuronal subpopulations are relatively spared 7 . Because of the clinical importance of MSNs in HD, differentiation protocols have been developed to generate MSNs from induced pluripotent stem cells (iPSCs) 8, 9 . However, modeling HD with iPSCderived neurons often requires additional cellular insults to detect HD-relevant phenotypes [10] [11] [12] [13] . For example, neurons differentiated from patient iPSCs showed elevated levels of caspase activity only upon trophic factor withdrawal, treatment with hydrogen peroxide, or high levels of glutamate, but otherwise display no overt cell death phenotype 9, 10, 13 . Additionally, iPSC-derived neurons do not exhibit mHTT aggregates even after the addition of cellular stressors 11 , and other studies required culturing cells for at least 6-8 months and treatment with proteasome inhibitors before aggregates could be detected 12, 14 . Therefore, an alternative reprogramming approach that generates an enriched population of patient-derived MSNs that more robustly display HD phenotypes will greatly facilitate the modeling of HD.
Ectopic expression of the brain-enriched microRNAs (miRNAs) miR-9/9* and miR-124 (miR-9/9*-124) in human adult fibroblasts has been shown to directly convert fibroblasts to neurons through extensive chromatin reconfigurations. The miRNA-9/9*-124-induced neuronal state, generated by miRNA instruction in switching the activities of chromatin remodeling complexes 15, 16 , allows terminal selector genes to guide neuronal conversion to produce a highly enriched population of specific neuronal subtypes 16 , specifically MSNs with CTIP2, DLX1, DLX2 and MYT1L (CDM) 17 . In contrast to neurons differentiated from iPSCs, in which the age stored in original fibroblasts is erased during the induction of pluripotency 18, 19 , directly converted neurons have been shown to retain age-associated marks of starting adult human fibroblasts, including the epigenetic age (also known as the epigenetic clock 19 ), oxidative stress, DNA damage, miRNAome, telomere lengths and transcriptome 20, 21 . This feature offers potential advantages in modeling adultonset disorders; however, the value of MSNs directly converted from HD patient fibroblasts in modeling HD remains to be determined.
Here we propose the generation of HD patient-derived MSNs (HD-MSNs) through miR-9/9*-124-CDM-based conversion of fibroblasts as a cellar model of HD. We focused on HD samples with 40-50 CAG repeats, which represent the majority of HD cases 4 . HD-MSNs recapitulated essential HD-associated phenotypes, including the formation of mHTT aggregates, DNA damage, spontaneous neuronal death in culture, and a decline in mitochondrial function. We further provide evidence that cellular age is an essential component underlying the manifestation of HD phenotypes. By inducing HD-fibroblasts into iPSCs and redifferentiating them back into embryonic fibroblasts for neuronal conversion, we discovered that age-associated reduction in protein homeostasis levels was MAP2-and 70-80% GABA-and DARPP-32-positive neurons (Fig. 1b,c) . Furthermore, CAG repeat lengths remained stable after neuronal conversion ( Supplementary Fig. 2 ).
We carried out whole-cell recordings to determine functional properties of HD-MSNs in comparison to Ctrl-MSNs. All recorded cells displayed multiple action potentials and robust inward and outward currents upon stimulation (Fig. 2) . HD-and Ctrl-MSNs displayed spontaneous action potentials at similar frequencies and had similar action potential thresholds (Fig. 2a-c) . Notably, more HD-MSNs than Ctrl-MSNs fired multiple action potentials (Fig. 2d) . However, all other passive membrane properties recorded did not differ significantly between HD-and Ctrl-MSNs (Fig. 2c) . To further access electrophysiological properties under the same recording condition, HD-MSNs (HD.40, HD.43 and HD. 44 ) and Ctrl-MSNs (Ctrl.17, Ctrl.18 and Ctrl. 19 ) were cocultured and recorded on the same coverslip ( Supplementary Fig. 3a) . At PID 35, all six reprogrammed lines fired action potentials, but, as in cells that were cultured separately, a higher percentage of HD-MSNs fired multiple action potentials than Ctrl-MSNs upon current injection ( Supplementary Fig. 3b ,c) and displayed spontaneous generation of action potentials ( Supplementary Fig. 3d ). Whereas passive membrane properties measured remained similar between HDand Ctrl-MSNs, we detected increased current responses with highvoltage stimulus in HD-MSNs ( Supplementary Fig. 3e-g ), reflecting increased excitability and firing complexity in HD-MSNs.
To further analyze the acquisition of MSN fate, we performed RNA sequencing (RNA-seq) at PID 32 and compared the gene expression profiles between fibroblasts and converted neurons in HD and control samples. Analysis of 15 representative fibroblast-associated genes and 53 genes highly enriched in the striatum revealed the 
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NATuRe NeuRoSCIeNCe successful acquisition of MSN fate in neurons converted from HD and control samples (Fig. 3a) . To identify genes potentially dysregulated in HD-MSNs, we carried out transcriptional analysis of seven independent HD-MSN and five Ctrl-MSN samples (Supplementary Table 1 ). Principal component analysis indicated sample segregation based on the genotype (mHTT vs. healthy control) as well as the sex of sample donors (Fig. 3b) . Analysis of protein-coding genes revealed 1,127 differentially expressed genes (DEGs) between sex-matched HD-MSNs and Ctrl-MSNs (false-discovery rate (FDR) ≤ 0.01 and log 2 (fold change) (LFC) ≥ 0.5 or ≤ -0.5) (Fig. 3c) . Gene ontology analysis showed DEGs in HD-MSNs to be significantly enriched for genetic networks associated with cell differentiation (P = 1.51 × 10 Table 2 ). Several DEGs identified in HD-MSNs have been previously implicated in HD. For example, we detected the upregulation of matrix metalloproteinase 9 (MMP9), which has been shown to be increased in postmortem human HD-affected brains 22 and to significantly decrease the survival of striatal neurons 23 . Moreover, our analysis revealed the downregulation of huntingtin-associated protein-1 (HAP1) in HD-MSNs (LFC -0.55 and FDR 5.04 × 10 −4
; Fig. 3c ), which has previously been shown to antagonize mHTT-mediated cytotoxicity and enhance cell viability 24 . Additionally, we detected the downregulation of 7-dehydrocholesterol reductase (DHCR7) in HD-MSNs (LFC -0.71 and FDR 2.8 × 10 ; Fig. 3c ), an enzyme previously shown to have reduced expression in patients and mouse models of HD and thought to be involved in HD-specific metabolic pathway alterations 25, 26 . Notably, many DEGs upregulated in HD-MSNs were associated with neurophysiological processes, such as the voltage-gated potassium channel subunit KCNA4 (LFC 1.15 and FDR 1.1 × 10 −4 ) ( Fig. 3c ) and several subunits of GABA type-A receptors and AMPA receptors, suggesting increased neurotransmission in HD-MSNs (Fig. 3c,d and Supplementary Fig. 4 ). We also detected upregulation of α -synuclein (SNCA) (LFC 1.15 and FDR 1.1 × 10
), an aggregation-prone protein shown to accumulate in mHTT polyglutamine inclusions 27 . Overexpression of α -synuclein has been reported to accelerate the onset of HD symptoms in multiple mouse models 28 . 
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Further, we found NTRK2 (also known as TRKB), the main receptor for brain-derived neurotrophic factor (BDNF), to be downregulated in HD-MSNs (LFC -0.77 and FDR 7.44 × 10 −3 ) (Fig. 3c) . The loss of BDNF in HD pathology has been investigated extensively and proposed to be critical in the degeneration of MSNs 29, 30 ; our results indicate that mHTT may induce downregulation of BDNF signaling at the receptor level in HD-MSNs. The impairment of TRKB receptor was suggested to mediate postsynaptic dysfunction of MSNs in mouse models of HD, although changes in NTRK2 mRNA levels were not detected in HD mouse models 31 . Our analysis also uncovered DEGs with no previous association with HD. For instance, SP9, a zinc finger transcription factor recently shown to be necessary for the maintenance and survival of striatopallidal MSNs Supplementary Fig. 4 ).
Mutant HTT aggregates in MSNs directly converted from HD-fibroblasts. Because polyglutamine expansion in HTT leads to the formation of insoluble structures of aggregated mHTT, or inclusion bodies 3 , we performed immunocytochemistry and ultrastructural and biochemical analyses to assess whether HD-MSNs would display mHTT inclusions. Notably, HD-MSNs exhibited mHTT aggregates, in contrast to their corresponding fibroblasts or Ctrl-MSNs (Fig. 4a-c) . Non-reprogrammed HD-fibroblasts were devoid of detectable aggregates even upon cellular insults, including the induction of oxidative stress with hydrogen peroxide or cellular senescence by serial passaging ( Supplementary Fig. 5a,b) . Furthermore, mimicking reprogramming using CDM factors with a nonspecific microRNA, a condition previously shown to be ineffective for neuronal conversion 17 , did not lead to detectable mHTT aggregates ( Supplementary Fig. 5c ), demonstrating the specificity of the aggregation phenotype to successfully reprogrammed neurons. Cytoplasmic (Fig. 4c,d ) and intranuclear ( Fig. 4d ) mHTT aggregates were evident in HD-MSNs reprogrammed from all HD patient samples as early as PID 14 when analyzed with antibodies (MW8 and EM48) that selectively recognize aggregated mHTT inclusion bodies colocalized with ubiquitin ( Fig. 4f and Supplementary Fig. 5d-f ). HD models that have been engineered to overexpress mHTT with a large number of CAG repeats report high levels of cells with inclusions. However, studies analyzing postmortem HD patient brains found that only up to 10% of MSNs showed inclusion bodies 33 , similar to the levels we detected in HD-MSNs (Fig. 4e) . Examining the ultrastructure of immunogold-labeled mHTT inclusions by transmission electron microscopy (TEM) in converted MSNs (HD. 40 and Ctrl.19) plated in microdishes (Fig. 4g ) revealed the presence of nanogold particles labeling mHTT aggregates, as well as structures of fibrillar morphology, found only in HD-MSNs ( Fig. 4h and Supplementary Fig. 6a,d) . We further confirmed the expression of Supplementary Fig. 7 ) using the monoclonal antibody MW1,which was shown to specifically detect the polyglutamine domain of HTT exon 1 while showing no detectable binding to normal HTT 34 . Additionally, insoluble aggregated HTT could be detected in all reprogrammed HD samples, but not in Ctrl-MSNs (Ctrl.16 MSNs) using the HTT aggregate-specific monoclonal antibody MW8 34 ( Supplementary Fig. 7 ). In our TEM studies, we found immunogold particles compartmentalized inside autophagosomes, cytosolic double-membrane vesicles involved in macroautophagy (Fig. 4i ). This suggests that autophagic vacuoles can recognize and trap cytosolic mHTT inclusions in HD-MSNs harboring low CAG repeats. In fact, we observed colocalization of mHTT and LC3-II, a well-established marker of autophagosomes, in HD-MSNs reprogrammed from three independent HD lines, which is similar to previously reported findings in a HD mouse model 35 ( Fig. 4i and Supplementary Fig. 6f ).
Induction of pluripotency alters mHTT aggregation propensity.
Because our findings contrasted with previous studies that report the lack of mHTT aggregates in iPSC-derived neurons from HD patients, we tested whether altering the cellular state of adult HD-fibroblasts to an embryonic-like stage 18 would affect the aggregation propensity of mHTT in HD-MSNs. We derived HD-iPSCs ; n.s. P = 0.99)). j, Microarray analysis of MSNs from neonatal or older healthy individuals shows reduction in ubiquitin-proteasome system (UPS) gene expression with age. Mean ± s.e.m.; n.s., not significant.
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NATuRe NeuRoSCIeNCe from adult HD fibroblasts and differentiated these iPSCs back into fibroblasts to generate human embryonic fibroblasts (HEFs) 18 ( Fig.  5a and Supplementary Fig. 8a) . Briefly, HD.40 fibroblasts were transduced with Sendai viral vectors to express the four reprogramming factors (OCT4, SOX2, KLF4 and c-MYC), which resulted in integration-free iPSCs that expressed markers of pluripotency , n.s. P = 0.80 and 0.90)). j, Representative RNA-seq tracks for SP9. Experiment was done once with 7 HD-MSN samples and 5 controls. k, Validation by qPCR with SP9-specific primers (two-tailed Student's t-test; *P = 0.027, t = 2.702, d.f. = 8; n = 5 independent HD and control lines). l, Restoring expression of SP9 by lentiviral transduction at PID 14 rescues cell death phenotype at PID 35. Quantification of SYTOX-positive cells as a percentage of Hoechst-positive (one-way ANOVA (F(3,8 = 9.792, P = 0.0047) with Tukey's test (from left, **P = 0.009 and 0.008, n.s. P = 0.99); averages of 1,000 cells from 3 independent samples per group). a-f, PID 30; i-l, PID 35; j PID 32. a-l, ***P < 0.001; **P < 0.01; *P < 0.05; n.s., not significant. Scale bars in a and e, 100 μ m; in c, 10 μ m; in g, 500 μ m. Mean ± s.e.m.
NATuRe NeuRoSCIeNCe and retained a normal karyotype and the same number of CAG repeats ( Supplementary Fig. 8b-e) . iPSC-derived HD-HEFs expressed fibroblast markers fibronectin and vimentin (Fig. 5b) . We confirmed that HD-HEFs exhibited cellular markers associated with the re-induction of an embryonic state, including high expression of the nuclear lamina-associated protein 2α (LAP2α ) 18 ( Supplementary Fig. 8f ). Upon direct conversion of HD-HEFs to MSNs (human embryonic MSNs, heMSNs), little to no aggregated mHTT was detectable in HD-heMSNs at PID 21 (Fig. 5c,d) . We further verified these results using another, independent iPSC line from a symptomatic 37-year-old HD patient with 50 CAG repeats in HTT (HD.50; Supplementary Fig. 8g,h ). We then investigated differences between adult MSNs and heMSNs in mHTT aggregation propensity to elucidate the contribution of aging to protein aggregation in HD. We began by ectopically expressing EGFP fused to 23 or 74 polyglutamine repeats (GFP-23Q or GFP-74Q) in either HD adult fibroblasts or HD-HEFs to track protein aggregation by live imaging (Fig. 5e) . While the expression of GFP-23Q stayed diffuse, we observed a rapid rate of GFP-74Q aggregate formation (Fig. 5e ) in adult fibroblasts, with over 70% of HD-fibroblasts 
NATuRe NeuRoSCIeNCe displaying GFP-74Q aggregates and increased fluorescence density indicating the formation of inclusion bodies after 24 h, whereas in HEFs aggregates were only visible in fewer than 10% of cells at each time point analyzed (Fig. 5f ). Given that aggregates can be induced by treatment with proteasome inhibitors in iPSC-derived MSNs 12 , we postulated that a higher proteasome activity in HEFs likely prevented GFP-74Q from forming aggregates. We performed qPCR analysis for 17 genes associated with the ubiquitin-proteasome system (UPS), the main protein quality control machinery in the cell, in HD adult fibroblasts and two lines of HEFs differentiated for cell death with SYTOX green (averages of 1,000 cells per group; one-way ANOVA (F(2,9) = 9.433, P = 0.0062) with post hoc Tukey's test (*P = 0.0115 and **P = 0.0084, n.s. P = 0.69)), oxidative DNA damage with 8-OHdG (one-way ANOVA (F(2,9) = 21.8, P = 0.0004) with post hoc Tukey's test (from left, ***P = 0.0006 and ***P = 0.0007, n.s. P = 0.54); averages of 100 cells per group) and mutant HTT inclusion bodies (IBs) with EM48 (averages of 100 cells per group; one-way ANOVA (F(2,9) = 9.911, P = 0.0053) with post hoc Tukey's test (*P = 0.0138 and **P = 0.0058, n.s. P = 0.46)). *P < 0.001; **P < 0.01; *P < 0.05; n.s., not significant; averages from 3 independent control lines, 6 independent pre-HD lines and 3 independent HD lines. Scale bars, 100 μ m except in right column of c, where they are 20 μ m. Mean ± s.e.m.
NATuRe NeuRoSCIeNCe from two independent HD-iPSC clones. We found eight genes consistently upregulated in HEFs (Supplementary Fig. 9 ). The upregulated UPS genes included the heat-shock transcription factor HSF1, a protein that regulates the expression of genes involved in protein homeostasis 36 and is reduced in the striatum of HD patients 37 .
To directly test whether proteasome activity was preventing the formation of inclusions in HEFs, we treated GFP-74Q-expressing HEFs with the proteasome inhibitor lactacystin. Lactacystin-treated HEFs had significantly more cells bearing inclusions than DMSO-treated HEFs (Fig. 5g) .
Although iPSCs have been previously shown to possess higher proteasome activities than their originating fibroblasts, differentiation of iPSCs into neurons also was shown to reduce proteasome activity 38 . To determine whether changes in the proteasome activity could account for the detection of mHTT aggregates in MSNs but not in heMSNs, we assessed the functional activity of the proteasome in converted MSNs with the fluorogenic peptide LLVY-AMC. We discovered that proteostasis was collapsed in HD-MSNs in comparison to heMSNs, which retained the proteasome activity comparable to that in iPSCs (Fig. 5h,i) . Aggregation propensity was not dependent on HTT mutation, as evidenced by similar levels of proteostasis between HD and control samples (Fig. 5f,i) . To explore the age-dependent collapse in proteostasis, we analyzed the expression of 300 UPS-associated genes in a previously published dataset generated by the transcriptional profiling of MSNs converted from fibroblasts of young (3 d, 5 months and 1 year old) or old (aged 90, 92 and 92 years old) donors 20 . By comparing gene expression in young versus old fibroblasts and MSNs, we determined that fibroblasts did not display drastic changes in the expression of UPS-related genes with age, but MSNs from older individuals showed a dramatic increase in the number of downregulated UPS-related genes ( Fig. 5j and Supplementary Fig. 9 ). In fact, gene ontology analysis of downregulated genes in old MSNs showed significant enrichment for the positive regulation of proteolysis (P = 2.01 × 10
−2
). These data suggest that the proteostasis collapse in MSNs, but not in originating fibroblasts or iPSC-derived neurons, depends on the cellular age of converted neurons.
mHTT-mediated DNA damage and spontaneous degeneration.
Because aging contributes to the onset of HD, we tested whether direct conversion would allow detection of spontaneous neuronal death in HD-MSNs. We first measured DNA damage in HD-MSNs converted from three independent HD patients in comparison to starting fibroblasts and Ctrl-MSNs. At PID 30, HD-MSNs exhibited increased oxidative DNA damage as determined by levels of 8-hydroxy-2′ -deoxyguanosine (8-OHdG) (Fig. 6a,b) , as well as increased double-stranded breaks as assessed by the presence of nuclear 53BP1-positive foci (Fig. 6c,d ). Analysis by single-cell gel electrophoresis that visualizes the migration of broken DNA strands from individual agarose-embedded cells (also known as the comet assay) showed a marked increase in comet tail lengths in comparison to Ctrl-MSNs at PID 30 while no significant difference was detected between HD and control fibroblasts (Fig. 6e,f) . Next we quantified spontaneous cell death in three controlled pairs of HD-and CtrlMSNs using SYTOX green, a nucleic acid stain impermeable to live cells, at multiple time-points during reprogramming (Fig. 6g,h ). Cell death levels were comparable at PID 30, but increased drastically for HD-MSNs in relation to their controls at PID 35 and 40 (Fig. 6h) , further evidenced by a stark reduction of DARPP-32-positive HD-MSNs (Supplementary Fig. 10 ). The detected DNA damage depended on HTT, as AAV-shRNA-mediated reduction of HTT significantly reduced 8-OHdG levels and number of 53BP1 foci in HD-MSNs (Fig. 6i) . Given that the neuronal death of HD-MSNs was preceded by extensive DNA damage, we tested whether HD-MSN cell death would be amenable to pharmacological intervention by treating HD-MSNs with KU60019, an inhibitor of ataxia-telangiectasia mutated (ATM) kinase. ATM is a central regulator of the DNA damage response activated upon DNA damage or oxidative stress to induce apoptosis, and KU60019 has been previously reported to reduce mHTT-induced cell death 39 . Consistent with these findings, we found that the treatment of HD-MSNs with 0.5 μ M KU60019 significantly reduced levels of spontaneous and stress-induced neuronal death in HD-MSNs (Supplementary Fig. 10 ).
We also discovered that the neuronal death seen in HD-MSNs was responsive to genetic perturbations. For instance, we found SP9, a transcription factor necessary for the maintenance and survival of MSNs 32 , to be significantly downregulated in HD-MSNs by RNA-seq analysis (Fig. 6j) and further validated it by qPCR in five independent HD-MSN samples (Fig. 6k) . We then cloned the cDNA of SP9 downstream of the ubiquitous EF1α promoter in a lentiviral vector to allow the consistent expression of SP9 in HD-MSNs. At PID 14 of neuronal conversion, three HD-MSN (HD.40, HD.42 and HD.46) and three Ctrl-MSN (Ctrl.16, Ctrl.17b and Ctrl.19) samples were transduced with lentivirus carrying the SP9 cDNA construct, cultured until PID 35, and then assayed for cell death with SYTOX green. We found that restoring SP9 expression in HD-MSNs reduced cell death to levels indistinguishable from those of controls (Fig. 6l) . Although loss of SP9 has been previously shown to lead to apoptosis of MSNs in mice 32 , further studies are needed to probe the neuroprotective mechanism of this transcription factor and its potential role in HD pathogenesis. Our results show that directly converted HD-MSNs could potentially serve as a useful platform for identifying pharmacological and genetic factors that have therapeutic potential for treating HD.
Mitochondrial dysfunction, oxidative stress and metabolic deficits in HD-MSNs. Ultrastructural analysis in HD-MSNs and CtrlMSNs (HD.40 and Ctrl.19) revealed HD-MSNs to be enriched with lipofuscin granules, aging pigments that accumulate due to incomplete lysosomal degradation of damaged mitochondria, which are commonly detected in the brains of HD patients 35, 40 ( Supplementary Fig. 6b,c) . HD-MSNs also exhibited high levels of mitophagy, a selective degradation of dysfunctional mitochondria typical of apoptotic cells 41 ( Supplementary Fig. 6e ). HD-MSNs further showed the accumulation of cytoplasmic lipid droplets, which are known to be caused by oxidative stress and mitochondrial dysfunction 42 ( Supplementary Fig. 6e ). To gain insight into the mitochondrial and metabolic dysfunction present in HD-MSNs, we reprogrammed six lines (HD.42, HD.46, HD.47, Ctrl. 19, Ctrl.20, Ctrl.17c and Ctrl. 18b; Supplementary Fig. 11 ) to quantify mitochondrial functions. We first determined, using the mitochondrial indicator MitoTracker Red, that the total pool of mitochondria was unchanged between HD-and Ctrl-MSNs (Fig. 7a) . We next assessed changes in the mitochondrial membrane potential with TMRE, an indicator of active and polarized mitochondria, and found significantly lower levels of TMRE signal in HD-MSNs, indicating decreased membrane potential of mitochondria (Fig. 7b) . Increased production of reactive oxygen species by mitochondria is thought to be a major cause of oxidative stress in HD and a critical component in the progression of the disease 43 . Live imaging of HD-MSNs with the superoxide indicator MitoSOX Red revealed significantly higher levels of reactive oxygen species in HD-MSNs (Fig. 7c) . HD-MSNs displayed significantly larger lipid droplets than controls as measured by the lipid dye BODIPY 498/503 (Fig. 7d) . Since our results indicated impaired mitochondrial health, we measured levels of mitophagy in HD-MSNs ( Supplementary  Fig. 11a ). Converted MSNs were labeled with MitoTracker and immunostained for the autophagosome marker LC3-II for colocalization analysis. Two out of three HD-MSNs derived from independent patients showed higher cytoplasmic LC3-II than controls, although the difference was not statistically significant ( Supplementary Fig. 11b ). However, we found a greater percentage Articles NATuRe NeuRoSCIeNCe of mitochondria and autophagosome colocalization in HD-MSNs ( Supplementary Fig. 11c ). Collectively, these results point to substantial mitochondrial dysfunction in HD-MSNs.
Differential vulnerability of neuronal subtypes to mHTT toxicity.
Although HTT is ubiquitously expressed throughout the brain, mHTT leads to selective degeneration of MSNs and, to a lesser extent, cortical neurons as the disease progresses 44 . Human postmortem studies have shown that, at a stage when neuronal loss is low in the cortex but high in the striatum, mHTT aggregates are more common in the cortex than in the striatum 33 . We hypothesized that conversion of HD fibroblasts to cortical neurons (HD-CNs) could model the selective vulnerability of HD-MSNs to neurodegeneration. We transduced control and HD-patient fibroblasts either with miR-9/9*-124-CDM or with miR-9/9*-124 in conjunction with NeuroD2, ASCL1 and MYT1L (DAM) (miR-9/9*-124-DAM), a transcription factor cocktail shown to guide the neuronal conversion to cortical neurons 45 ( Supplementary Fig. 12a-c) . Surprisingly, HD-CNs exhibited lower levels of DNA damage ( Supplementary  Fig. 12d ,e) and cell death than HD-MSNs ( Supplementary Fig. 12f ) but a higher level of mHTT aggregation, (Supplementary Fig. 12g ), suggesting that cellular properties intrinsic to MSNs render them differentially vulnerable to neurodegeneration.
Manifestation of HD cellular phenotypes is dependent on patient age.
The maintenance of aging signatures upon neuronal conversion has long been postulated to be an important advantage of using directly converted patient neurons to model late-onset diseases. However, no studies have provided empirical evidence that age information stored in a donor's somatic cells contributes to the manifestation of disease-related phenotypes in converted neurons. Even though our findings from HD-heMSNs were insightful (Fig. 5) , to further evaluate the significance of cellular age in HD phenotype manifestation in HD-MSNs we investigated the properties of MSNs reprogrammed from HD-fibroblasts sampled before disease onset. We acquired six fibroblast lines from presymptomatic HD patients (pre-HD), sampled 13 to 17 years before the onset of clinical symptoms, with CAG tract sizes of 42-49 repeats (Supplementary Table  1 ). All six pre-HD fibroblasts were reprogrammed using miR-9/9*-124-CDM to generate MSNs (pre-HD-MSNs), alongside fibroblasts from three controls and three symptomatic HD patients (Fig. 8a,b) . Pre-HD-MSNs were less vulnerable to mHTT-induced toxicity at PID 35, with lower levels of cell death and oxidative DNA damage (Fig. 8c,d) . Notably, pre-HD-MSNs still contained mHTT aggregates at a level similar to that in symptomatic HD-MSNs (Fig.  8c,d) . These results are noteworthy as they directly show that the age-dependent onset of HD can be modeled with directly converted HD-MSNs, which provide a human cellular model for examining the contributions of age and genetic factors to disease onset.
Discussion
Since neurological disorders often affect distinct neuronal subpopulations, studies using generic protocols to induce unrestricted neuronal fates are likely only capturing a partial snapshot of factors that contribute to disease onset and progression. The direct conversion of fibroblasts of symptomatic HD patients generates MSNs that retain their cellular age status. To test the involvement of cellular age in the manifestation of disease-relevant phenotypes in HD-MSNs, we applied two distinct cellular reprogramming approaches that diverge in the maintenance of age signatures from donor cells. The induction of pluripotency has been well documented to erase age marks and reset the age of donor cells to an embryonic state 18, 19 while direct neuronal conversion has been shown to maintain agerelated transcriptional, cellular and epigenetic signatures 20, 21 . In this study, we demonstrate that age retention through direct neuronal conversion is crucial for modeling HD, exemplified by the detection of mHTT aggregates, a direct reflection of the age-associated decline in proteostasis that is absent in iPSC-derived neurons.
We found that mHTT-induced DNA damage contributed to the spontaneous degeneration of HD-MSNs, as treating the cells with an inhibitor of the DNA damage response protein ATM rescued the cell death phenotype, similarly to iPSC-derived neurons undergoing degeneration upon BDNF withdrawal 39 . We also provide evidence that controlling the specificity of MSN fate during neuronal conversion is critical for the manifestation of disease phenotypes, as altering the terminal neuronal fate of HD-fibroblasts to CNs drastically reduced the levels of DNA damage and cell death, despite the persistence of mHTT aggregates. Although cortical neurons are not completely spared in HD, they degenerate at a much slower rate during disease progression than MSNs, even though mHTT aggregates are more common in the cortex than in the striatum 33 . Accordingly, postmortem studies in HD patients have also shown significantly less DNA damage in the cortex than in the striatum 46 . The cellular properties that render MSNs selectively vulnerable to mHTT-induced toxicity are poorly understood, and subtype-specific neuronal conversion approaches may offer an experimental means to examine neuroprotective attributes in discrete neuronal subtypes. The ability to model the progression of HD in an age-dependent manner provides a patient-based platform for applications in human disease modeling and a means to gain mechanistic insight into the pathogenesis of HD.
Methods
Methods, including statements of data availability and any associated accession codes and references, are available at https://doi. org/10.1038/s41593-018-0075-7.
Immunocytochemistry. Cells were fixed using 4% paraformaldehyde (PFA) for 20 min and permeabilized using 0.2% Triton-X solution for 10 min following three phosphate-buffered saline (PBS) washes. Cells were blocked for 1 h at room temperature using 1% normal goat serum (NGS) and 5% bovine serum albumin (BSA) in PBS. Primary antibodies were added in the presence of blocking buffer overnight at 4 °C. Secondary antibodies were added following three PBS washes at 1:1,000 in blocking buffer at room temperature for 1 h. The following primary antibodies were used for the immunofluorescence studies: mouse anti-MAP2 (Sigma-Aldrich #M9942 clone HM2, 1:750), rabbit anti-β -III tubulin (BioLegend #MMS-435P, 1:2,000), chicken anti-NeuN (Aves, #NUN 1:500), rabbit anti-GABA (Sigma #A2052, 1:2,000), mouse anti-GABA (Sigma #A0310 clone GB-69, 1:500), rabbit anti-DARPP32 (Santa Cruz Biotechnology #sc-11365, 1:400), rabbit anti-S100A4 (FSP1) (Abcam #124805, 1:200), mouse anti-HTT (mEM48, Millipore #MAB5374, 1:50) (MW8, Developmental Studies Hybridoma Bank, 1:100), rabbit anti-ubiquitin (Abcam #ab7780, 1:50), mouse anti-vimentin (Sigma-Aldrich, #V6630 1:500), rabbit anti-fibronectin (Sigma-Aldrich, #F3648 1:500), mouse anti-phospho-histone H2A.X (Millipore #05-636-I, 1:200), rabbit anti-lap2-α (Abcam #ab5162, 1:500), rabbit anti-53BP1 (Abcam #ab21083, 1:200), mouse anti-8OHdG (Santa Cruz Biotechnology #sc-139586, 1:1,000), rabbit anti-LC3B (Sigma-Aldrich # L7543, 1:1,000). The secondary antibodies were goat anti-rabbit or mouse IgG conjugated with Alexa-488, Alexa-594 or Alexa-647 (Invitrogen).
Images were captured using a Leica SP5X white light laser confocal system with Leica Application Suite (LAS) Advanced Fluorescence 2.7.3.9723. All staining quantification was performed by counting number of positive-stained cells over DAPI signal. Antibodies were validated by staining fibroblasts as negative controls, and they exhibited low background.
Immunoblot analysis. At PID 28, cells were lysed in SDS lysis buffer (1 M TrisHCl pH 6.8, 2% SDS, 30% glycerol) supplemented with protease inhibitors (Roche, #04693132001). The concentrations of whole-cell lysates were measured using the Pierce BCA protein assay kit (Thermo Scientific, #23227). Equal amounts of whole cell lysates were resolved by SDS-PAGE and transferred to a nitrocellulose membrane (GE Healthcare Life Sciences, #10600006) using a transfer apparatus according to the manufacturer's protocols (Bio-Rad). After incubation with 5% BSA in TBS containing 0.1% Tween-20 (TBST) for 30 min, the membrane was incubated with primary antibodies at 4 °C overnight: MW8 (Developmental Studies Hybridoma Bank, 1:500) and MW1 (Developmental Studies Hybridoma Bank, 1:500). Following incubation, membranes were incubated with a horseradish peroxidase-conjugated anti-mouse or anti-rabbit antibody for 1 h. Blots were developed with the ECL system (Thermo Scientific, #34080) according to the manufacturer's protocols.
Mitochondrial assays. The cell-permeant mitochondrial indicator MitoTracker Red CMXRos (ThermoFisher Scientific #M7512) was added directly to live cells at final concentration of 50 nm in serum-free medium. After 20 min of incubation in 37 °C, cells were imaged with an epifluorescence microscope and then fixed and processed for immunostaining as described above. Analysis of colocalization of MitoTracker Red and LC3-II (Anti-LC3B antibody, Sigma-Aldrich # L7543) was performed using Metamorph bioimaging software after image acquisition using a Leica SP5X white light laser confocal system with Leica Application Suite (LAS). Mitochondrial membrane potential was assayed with the TMRE Mitochondrial Membrane Potential Assay Kit (Abcam #ab113852) following the manufacturer's protocol. Briefly, TMRE was added to live cells at a final concentration of 20 nm in serum-free medium. After 15 min of incubation at 37 °C, coverslips were removed from medium and Vaseline was applied to edges of coverslips to create a rim for live mounting and microscopy and imaged using a Leica SP5X white light laser confocal system with Leica Application Suite (LAS). Lipid droplets were stained with BODIPY 493/503 (4,4-difluoro-1,3,5,7,8-pentamethyl-4-bora-3a,4a-diaza-sindacene) (ThermoFisher Scientific #D3922) at a final concentration of 0.1 μ m in serum-free medium. After 30 min of incubation in 37 °C, cells were imaged with an epifluorescence microscope and quantified with Leica Application Suite (LAS) quantification tools.
Electrophysiology. Whole-cell patch-clamp recordings were performed at PID 28-35 with miR-9/9*-124-CDM. At PID 14, cells undergoing reprogramming were transduced with pSYNAPSIN tRFP or GFP, and the next day they were trypsinized and plated together on top of rat primary neurons and glia isolated from perinatal pups, with the exception of recordings shown in Supplementary Fig. 3h , which were performed in monoculture in the absence of rat primary cells. Fluorescent reporter expression was visible within days and remained segregated for each population. Data were acquired using pCLAMP 10 software with MultiClamp 700B amplifier and Digidata 1550 digitizer (Molecular Devices). Electrode pipettes were pulled from borosilicate glass (World Precision Instruments) and typically ranged between 4 and 6 MΩ resistance. Solutions used to study intrinsic neuronal properties were the same as previously reported 17 . Postsynaptic potentials were detected spontaneously. Data were collected in Clampex and initially analyzed in Clampfit (Molecular Devices).
RNA extraction and gene expression profiling. Total RNA was extracted and isolated with TRIzol reagent (Thermo Fisher Scientific) according to manufacturer's instructions. cDNA was generated from isolated RNA with Superscript III Reverse Transcriptase (Thermo Fisher Scientific) primed with random hexamers. qPCR was performed with the primer sets listed in Supplementary Table 3 . For RNA-seq, reads were aligned to the human genome (assembly hg38) with STAR version 2.4.2a [23104886] . Gene counts were derived from the number of uniquely aligned unambiguous reads by Subread:featureCount [23558742], version 1.4.6, with GENCODE gene annotation (V23) [22955987] . All gene-level transcript counts were then imported into the R/Bioconductor package EdgeR [19910308] and TMM normalized to adjust for differences in library size. Genes not expressed in any sample were excluded from further analysis. The fits of the trended and tagwise dispersion estimates were then plotted to confirm proper fit of the observed mean-to-variance relationship, where the tagwise dispersions are equivalent to the biological coefficients of variation of each gene. Differentially expressed genes were then filtered for those having foldchanges (FC) > 1.5 together with false-discovery rate (FDR) adjusted P-values ≤ 0.05. Gene expression heat maps were generated using Z-scores for expression values of each gene among different samples (GENE-E Matrix Visualization and Analysis Platform, Broad Institute). MSN-specific genes were selected from previous studies that have profiled transcriptome profiles of isolated MSNs 48 . RNA-seq data are publicly available at GEO (accession code GSE84013).
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Dead-cell staining. SYTOX green nucleic acid staining (Thermo Fisher Scientific) was performed following manufacturer's suggestions, adapted as follows: a final concentration of 0.1 μ M SYTOX green was added directly to the medium of live cells. In addition, Hoechst 33342 solution (Thermo Fisher Scientific) was added as a counterstain to label all nuclei at a final concentration of 1 μ g/ml in culture medium. Samples were incubated for at least 10 min in 37 °C. Images were captured using a Leica DMI 400B inverted microscope with Leica Application Suite (LAS) Advanced Fluorescence. Three images were taken from random areas of each coverslip for at least three biological replicates per experiment. Quantification performed by counting number of SYTOX-positive cells over total Hoechst signal.
Comet assay. DNA damage was assessed by using the CometAssay reagent kit for single-cell gel electrophoresis assay (Trevigen, MD USA), following the recommended protocol for neutral conditions and adapting the gel electrophoresis methods for use in the Sub-Cell GT electrophoresis system (Bio-Rad, CA USA). Briefly, cells were collected from coverslips by treatment with 0.25% trypsin, pelleted, resuspended at 100,000 cells/ml in DPBS (Ca 2+ and Mg 2+ free; Thermo Fisher Scientific) and verified to be greater than 95% viable by trypan blue exclusion using an automated cell counter before continuing analysis. Approximately 5,000 cells were embedded in low-melting agarose, plated on slides and lysed overnight. The next day, electrophoresis was run at 30 V for 30 min in 1× TBE (National Diagnostics). Samples were fixed in 70% ethanol for 5 min, and slides were immersed in TE buffer pH 8.0 (Ambion) with SYBR green nucleic acid stain (10,000× , Thermo Fisher Scientific). Fluorescence images were captured using a Leica DMI 400B inverted microscope for scoring. In addition, an embryoid body formation assay confirmed the potential for acquisition of all three germ layers. iPSCs were expanded on ES-grade Matrigel (Corning)-coated plates cultured in mTeSR medium (Stemcell Technologies) or DMEM/F-12 with 20% KnockOut Serum Replacement, 1% GlutaMAX, 0.1 mM NEAA, 10 ng/mL fibroblast growth factor-basic (bFGF) and 55 μ M BME. To differentiate iPSCs into human embryonic fibroblasts (HEFs), culture medium was replaced with DMEM plus 20% FBS without bFGF for at least three passages. HEFs were transduced and reprogrammed to MSNs following our established protocol previously reported in detail 47 . Drug treatment. The ATM kinase inhibitor KU-60019 was obtained from Abcam (ab144817), solubilized in DMSO and directly added to the cell culture medium for a final concentration of 0.5 μ M at 30 d after miR-9/9*-124 induction, and then cell death was assessed by SYTOX at PID 35. Controls were treated with the same volume of DMSO but no drug. At day 35, cells treated with DMSO or KU-60019 also were treated with 1 mM H 2 O 2 for 3 h. SYTOX green and Hoechst stain were added as already described and imaged for scoring. 20 S proteasome activity assay. Adherent cells were dissociated with 0.25% trypsin, pelleted by centrifugation and washed in cold PBS twice. Cell pellets were then resuspended in chilled cell lysis buffer (50 mM HEPES (pH 7.5), 5 mM EDTA, 150 mM NaCl, 1% Triton X-100 and 2 mM ATP) and incubated on ice for 30 min, vortexing every 10 min. Cell lysates were then centrifuged at 15,000g for 15 min at 4 °C. Lysate was then transferred to a microcentrifuge tube, and 10 μ l of each sample was used to determine protein concentration with a BCA protein assay kit (Thermo Scientific, Prod. #23227) following the manufacturer's recommendations. Proteasome activity was assayed using 10 μ g of each lysate with a 20 S proteasome activity assay kit (Millipore, APT280). Fluorescence intensity was measured every 5 min for 1 h with a microplate reader. Data were analyzed following previously reported methods 38 .
Generation of iPSCs and derivation of
Electron microscopy. Cells cultured in gridded glass-bottom μ -dishes (Ibidi, Madison, WI) were fixed with EM grade 4% PFA + 0.05% glutaraldehyde (GA) (Electron Microscopy Sciences) in PBS with 2 mM CaCl 2 at 37 °C for 5 min (min) then transferred to ice for 1 h. Samples were then incubated for 5 min in 50 mM glycine in PBS and permeabilized with 0.05% saponin with 1% BSA in PBS for 30 min. Cells were blocked with 1% BSA in PBS for 15 min and incubated with primary antibodies (mouse anti-HTT (MW8), 1:100, and rabbit anti-β -III tubulin BioLegend, 1:2,000) at room temperature for 2 h with gentle agitation. After washing in PBS-BSA three times for 10 min each, cells were incubated for an additional 2 h with Alexa Fluor 594 fluoro-nanogold secondary antibody (Nanoprobes, Yaphank, NY #7301) at a 1:250 dilution in PBS and 1% BSA at room temperature with gentle agitation while wrapped in foil. After washing in PBS three times for 10 min each, cells were fixed with 1% GA for 5 min and labeled with DAPI (1:10,000) for 5 min. After fluorescence imaging, the samples were rinsed twice in ultrapure water for 1 min each and then rinsed in 0.02 M citrate buffer (pH 4.8) three times for 5 min each. The fluoro-nanogold label was silver enhanced using HQ Silver (Nanoprobes, Yaphank, NY) for 9-11 min and the samples immediately rinsed with ultrapure water twice for 5 min each. The culture dishes were then rinsed in PBS buffer three times for 10 min each and subjected to a secondary fixation step for 1 h in 1% osmium tetroxide, 0.3% potassium ferrocyanide in PBS on ice. The samples were then washed in ultrapure water three times for 10 min each and then stained en bloc for 1 h with 2% aqueous uranyl acetate. After staining was complete, samples were briefly washed in ultrapure water, dehydrated in a graded ethanol series (50%, 70%, 90%, 100% twice) for 10 min in each step, and infiltrated with microwave assistance (Pelco BioWave Pro, Redding, CA) into LX112 resin. Samples were cured in an oven at 60 °C for 48 h. Once the resin was cured, the gridded glass coverslips were etched away with concentrated hydrofluoric acid and the exposed cells were excised with a jeweler's saw and mounted onto blank resin blocks with epoxy, oriented in the coverslip growing plane. Sections 70 nm thick were then taken and imaged on a TEM (JEOL JEM 1400 Plus, Tokyo, Japan) at 80 KeV.
Statistics. For all quantified data, multiple cells were counted from at least three biological replicates from multiple independent experiments or multiple lines. Statistical analyses were performed in GraphPad Prism using a two-tailed Student's t-test or a one-way ANOVA followed by a post hoc Tukey's test with P < 0.05 considered significant. Multiple comparisons were corrected with the Bonferroni or Holm-Sidak method as described in the figure legends. Studies were performed blindly and automated whenever possible with the aid of ImageJ cell counting tools, and multiple investigators confirmed quantification results. Data distribution was assumed to be normal, but this was not formally tested. Data in graphs are expressed as mean and error bars represent s.e.m. unless noted otherwise. Outliers were detected and excluded with Grubbs' test for α levels of 0.05. In total for this study, only two data points were excluded, from the Supplementary Fig. 10c,d control DMSO group (9 total data points), following pre-established criteria. No statistical methods were used to predetermine sample sizes, but our sample sizes are similar to those reported in previous publications [11] [12] [13] . Data collection was not randomized, but was always done in parallel with controls. Allocation of primary patient cells acquired from Coriell Biorepository into the HD group was done randomly. Samples were allocated into the Control group by age-and sex-matching healthy controls with HD samples acquired and available through Coriell Biorepository.
Life Sciences Reporting Summary. Further information on experimental design is available in the Life Sciences Reporting Summary.
Data availability. Gene expression data generated for this study have been made public at NCBI's Gene Expression Omnibus (GEO), accession GSE84013. All other data supporting the findings of this study are available from the corresponding author upon reasonable request.
A step-by-step protocol for this study is available at Nature Protocols All data quantified is the product of at least three biological replicates from at least three independent individuals. No sample size calculation was done, and small sample sizes were adequate to our analysis as samples display small variance, and contained equivalent sample sizes to similar recent studies, as detailed in our methods section, under statistics.
Data exclusions
Describe any data exclusions.
Outliers were detected and excluded with Grubbs' test for alpha levels of 0.05. In total for this study, 1 data point was excluded from each of Supplementary Fig. 11A and Supplementary Fig. 11B that met the pre-established criteria, as reported in statistic methods.
Replication
Describe the measures taken to verify the reproducibility of the experimental findings.
The experiments were conducted and analyzed independently by three investigators and therefore determined to be reproducible. For all experiments, all attempts at replication were successful.
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
Primary fibroblasts included in this study met two criteria. 1) It was available through the Coriell Biorepository and 2) confirmed mutation in the gene Huntingtin with CAG expansion lower than 50 repeats. Besides meeting this criteria, allocation of HD patient cells into "HD group" was done randomly. Samples into the "Control group" were allocated by age-and sexmatching healthy controls with HD samples acquired and available through Coriell Biorepository. One additional sample was added from Washington University iPSC core to the "control group" to match an HD patient that similar age and sex control was not secured through Coriell, (Healthy female in early 50s).
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
To further build confidence in our findings, we had two additional lab members reanalyze our data by counting thousands of cells blindly. In addition, we used the assistance of automated counting in ImageJ to standardize the procedures as much as possible. We have included this information in our methods and statistics sections and added acknowledgments to thank these additional lab members involved.
Note: all in vivo studies must report how sample size was determined and whether blinding and randomization were used.
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Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided 
Software
Policy information about availability of computer code
Describe the software used to analyze the data in this study.
Clampfit, EdgeR, Graphpad Prism, ImageJ, Leica LAS AF Lite, IGV, GENE-E, MetaCore. No custom codes were developed for this study.
For manuscripts utilizing custom algorithms or software that are central to the paper but not yet described in the published literature, software must be made available to editors and reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). Nature Methods guidance for providing algorithms and software for publication provides further information on this topic.
Materials and reagents
Policy information about availability of materials
Materials availability
Indicate whether there are restrictions on availability of unique materials or if these materials are only available for distribution by a third party. 
Animals and human research participants
Policy information about studies involving animals; when reporting animal research, follow the ARRIVE guidelines
Description of research animals
Provide all relevant details on animals and/or animal-derived materials used in the study.
No animals were used in this study.
Policy information about studies involving human research participants
Description of human research participants
Describe the covariate-relevant population characteristics of the human research participants.
Available from cell source at the Coriell Institute, and listed on Supplementary Table 1 . In regards to de-identified skin fibroblasts samples and induced pluripotent stem cells (iPSCs) acquired from the Coriell Institute for Medical Research, we do not have access to the master list to re-identify subjects. This activity is not considered to meet federal definitions under the jurisdiction of an Institutional Review Board, and thus exempt from the definition of human subject.
